Efficacy and Safety of Pirfenidone in Patient With Systemic Sclerosis-associated Interstitial Lung Disease
Clinical trial NCT03856853 · UNKNOWN
Trial details
- NCT number
- NCT03856853
- Sponsor
- Beijing Continent Pharmaceutical Co, Ltd.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-15
- Primary completion
- 2021-02-10
- Enrollment
- 144
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.